Introduction
Hectd1 mutant embryos show exencephaly (Zohn et al., 2007) , a neural tube defect that occurs when the anterior neural tube fails to close completely during embryonic development. These congenital malformations represent some of the most common birth defects in humans (Zohn and Sarkar, 2008) . Proper closure of the neural tube is dependent on the orchestration of several complex cellular processes in both the neural tissue and surrounding epithelium and mesenchyme (Copp et al., 2003; Copp, 2005) . Importantly, elevation of the anterior neural folds is mediated by expansion of the extracellular matrix, which in turn results in increased spacing of the cells in the mesodermderived cranial mesenchyme (CM; Morriss and Solursh, 1978a,b; Schoenwolf and Fisher, 1983; Morris-Wiman and Brinkley, 1990a,b,c) . Defects in expansion of the CM are associated with exencephaly in rodent models of neural tube defects. For example, treatment of rat embryos during neurulation with hyaluronidase prevents expansion of the extracellular matrix, resulting in collapse of the CM and delayed neural tube closure . Furthermore, exencephaly in Twist mutants is associated with reduced CM (Chen and Behringer, 1995) , whereas we have shown that exencephaly in Hectd1 mutant embryos is associated with denser mesoderm-derived CM (Zohn et al., 2007) .
Hectd1 encodes a novel homologous to E6-AP C-terminal (HECT)-domain containing E3 ubiquitin (Ub) ligase (Zohn et al., 2007) . Ubiquitination involves a three-enzyme cascade (E1, E2, and E3), resulting in the conjugation of Ub as single (monoubiquitination; Ub) or multiple (multi-or polyubiquitination; Ub n ) moieties onto either lysine (K) residues or the N terminus of substrate proteins (Pickart, 2001) . The functional significance of Ub n is dependent on which K residues in Ub are used to form the chain. Conjugation onto K48 of Ub generally targets a substrate for proteasomal degradation, whereas K63-linked Ub chains regulate a multitude of processes including intracellular protein localization and trafficking (Mukhopadhyay and Riezman, 2007) .
H ectd1 mutant mouse embryos exhibit the neural tube defect exencephaly associated with abnormal cranial mesenchyme. Cellular rearrangements in cranial mesenchyme are essential during neurulation for elevation of the neural folds. Here we investigate the molecular basis of the abnormal behavior of Hectd1 mutant cranial mesenchyme. We demonstrate that Hectd1 is a functional ubiquitin ligase and that one of its substrates is Hsp90, a chaperone protein with both intra-and extracellular clients. Extracellular Hsp90 enhances migration of multiple cell types. In mutant cranial mesenchyme cells, both secretion of Hsp90 and emigration of cells from cranial mesenchyme explants were enhanced. Importantly, we show that this enhanced emigration was highly dependent on the excess Hsp90 secreted from mutant cells. Together, our data set forth a model whereby increased secretion of Hsp90 in the cranial mesenchyme of Hectd1 mutants is responsible, at least in part, for the altered organization and behavior of these cells and provides a potential molecular mechanism underlying the neural tube defect.
control cells (Fig. 1, E and F) . Hectd1 mutant CM cells appeared larger than in wild-type CM. To quantitate these differences, cell area ( Fig. 1 G) and cell perimeter were measured in hematoxylin and eosin-stained CM sections of embryonic day 9.5 (E9.5) wild-type and Hectd1 mutant embryos, and these values were used to calculate a shape coefficient (Fig. 1 H) (Fig. 1, E-H) . Mesoderm-derived CM cells are not generally considered a migratory population of cells. Rather, elevation of the neural folds is thought to be driven by the expansion of the extracellular matrix, displacing CM cells and leading to increases in the space between individual cells of the CM (Morriss and Solursh, 1978a,b; Schoenwolf and Fisher, 1983; Morris-Wiman and Brinkley, 1990a,b,c) . Nevertheless, we have found that cells will migrate from CM explants when cultured on fibronectin-coated plates. To establish that the aberrant morphology observed in the CM of Hectd1 mutant embryos represents altered behavior of mutant cells, we performed a CM explant outgrowth assay. For these experiments, CM explants from E8.5 wild-type and Hectd1 O embryos were microdissected and cultured on fibronectin-coated plates. We chose fibronectin as a substrate, as it is commonly used in these types of outgrowth assays, is generally associated with cell migration during embryonic development, and is a component of the extracellular matrix in the CM (Tuckett and Zohn et al., 2006) .
Analyses of the mean number of cells emigrating from the explants demonstrated that Hectd1
O mutant CM cells emerge from the explant at a significantly (P < 0.05) higher rate than wildtype cells (Fig. 1, I -L and N). In addition, Hectd1
O mutant CM cells migrated significantly (P < 0.05) further from the explant than wild-type cells (Fig. 1 M) . Differences in emigration of Hectd1 O mutant cells could reflect differences in proliferation or death in the CM; however, our previous results indicate that these are not altered in Hectd1 mutant CM (Zohn et al., 2007 O -null mutants (Zohn et al., 2007) , which indicates that the HECT domain is necessary for the biological activity of Hectd1. To establish that Hectd1 is a functional E3 Ub ligase, full-length HA-tagged constructs encoding wild-type Hectd1 (pCMV-HA-Hectd1) or a ligase incompetent version of Hectd1 (pCMV-HA-Hectd1*), in which the conserved active site cysteine 2579 is mutated to glycine (Fig. 2 A) , were transfected into human embryonic kidney 293T (HEK293T) cells. To assess the effect of the proteasome on the stability of proteins ubiquitinated by Hectd1, cultures were treated for Heat shock proteins (Hsps) constitute a family of abundantly expressed protein chaperones that regulate numerous cellular functions, including protein folding and cell migration. Although the majority of studies on Hsp90 demonstrate intracellular functions, recent data establish that Hsp90 is secreted from the cell, stimulating enhanced motility (Eustace and Jay, 2004; Tsutsumi and Neckers, 2007) . Although the full extent of extracellular client proteins remains unknown, Hsp90 is thought to exert its effect on cell motility in the extracellular space through its chaperone activity on cell surface receptors and extracellular matrix components (Tsutsumi and Neckers, 2007; Li et al., 2012) . Furthermore, in spite of their clear importance in regulating migration outside the cell, our current understandings of the mechanisms controlling Hsp90 secretion remain fragmentary. Cell stressors such as treatment with proteasome inhibitors, heat shock, and hypoxia stimulate Hsp translocation to the membrane and/or secretion (Liao et al., 2000; Verschuure et al., 2002; Clayton et al., 2005; Li et al., 2007) . Hsp90 does not have a signal sequence and is released from the cell in exosomes, secretory vesicles targeted for fusion with the plasma membrane (Hegmans et al., 2004; Cheng et al., 2008; McCready et al., 2010) . Sorting of proteins into secretory vesicles is typically regulated by phosphorylation and/or ubiquitination (Bonifacino and Traub, 2003; Urbé, 2005) . Accordingly, phosphorylation by protein kinase A (PKA) is required for both membrane translocation and secretion of Hsp90 (Wang et al., 2009) . In contrast, the role of ubiquitination in Hsp90 secretion has not been explored.
Neural tube defects observed in Hectd1 mutants illustrate its critical importance during embryonic development; however, the key substrates regulated by Hectd1 remain unknown. Our previous and present studies show that Hectd1 is important for the organization of the CM, which facilitates elevation of the cranial neural folds and neural tube closure (Zohn et al., 2007) . Here we find, for the first time, that Hectd1 functions as a Ub ligase in vivo and binds to Hsp90, resulting in its K63-linked Ub n . We demonstrate that Hectd1-dependent Ub n of Hsp90 influences its intracellular localization and negatively regulates its secretion, as in the absence of Hectd1 Ub ligase activity, extracellular Hsp90 levels are increased. Furthermore, we show that the disorganized CM in Hectd1 mutant embryos, a potential underlying cause of exencephaly, is due at least in part to the abnormal behavior of CM cells stimulated by the excess Hsp90 secreted from mutant cells.
Results

Exencephaly in Hectd1 mutant embryos is associated with abnormal emigration of CM cells from explants
Our previous studies pointed to a failure of CM expansion as a potential underlying cause of exencephaly in Hectd1 mutants (Fig. 1, A-F ; also see Fig. 2 A for diagrams of Hectd1 mutant alleles used in this study; Zohn et al., 2007) . In addition to the increased cell density of mesoderm-derived CM cells in Hectd1 mutants previously noted (Zohn et al., 2007) (Fig. 2 C) . Significantly, this HMW band is not detected in Hectd1 X mutant lysates, where the Ub ligase domain of Hectd1 is disrupted, indicating that the HMW band represents Hectd1 auto-ubiquitination (Fig. 2 C) . Additionally, Hectd1 incorporates K63-linked Ub n chains in vivo that are absent in Hectd1 X mutant CM cells (Fig. 2 D) . Because conjugation of K63-linked Ub n chains onto substrate proteins generally serves nonproteolytic functions, this result further suggests that Hectd1-dependent Ub n is unlikely to target substrates to the proteasome for degradation. 4 h before lysis with the cell-permeable proteasomal inhibitor MG132 (carbobenzoxy-leucyl-leucyl-leucinal). Western blots of Hectd1-immunoprecipitated lysates were probed with anti-Ub antibodies, revealing that cells expressing HA-Hectd1 contain significantly more Ub-conjugated proteins bound to Hectd1 than cells expressing cysteine mutant HA-Hectd1* (Fig. 2 B) . These results demonstrate that Hectd1 exhibits Ub ligase activity. Furthermore, because Ub proteins are not stabilized by proteasomal inhibition, Hectd1 substrates are likely not targeted for proteasomal degradation.
We also examined the Ub ligase activity of Hectd1 in vivo (Fig. 2, C and D) . For these experiments, we took advantage of our two mutant mouse lines (Fig. 2 A; Zohn et al., 2007) . The Hectd1 O allele contains a nonsense mutation resulting in truncation of Hectd1, whereas the Hectd1 X allele contains a gene trap insertion disrupting the catalytic HECT domain but leaving the ). This region includes the charged domain 1 (CD1, amino acids 237-271) and ATPase domain (272-617), and is highly homologous to Hsp90 in primary amino acid sequence (red bar in Fig. 3 A) . The second approach used liquid chromatography-mass spectrometry (LC-MS) to screen for proteins that coimmunoprecipitated with endogenous full-length Hectd1 from E12.5 mouse embryo heads. From this screen, seven peptide fragments of Hsp90 were found (dots in Fig. 3 A and Fig. 3 , B and C). Identification of Hsp90 in both proteomic screens suggested that members of the Hsp90 superfamily may be substrates of Hectd1.
Hectd1 and Hsp90 physically interact
To explore the interaction between Hectd1 and Hsp90 (the Hsp90 isoform was used in all assays), we performed a series
Loss of Hectd1 affects the global cellular
Ub protein pool
To determine the extent of cellular ubiquitination influenced by Hectd1, Ub proteins were enriched from lysates of CM cultures isolated from the cranial region of E12.5 Hectd1 W and Hectd1 X mutant embryos. To enrich for Ub proteins, cell lysates were incubated with the Ub-binding protein Rad23 bound to agarose beads (Chen and Madura, 2002; HartmannPetersen and Gordon, 2004) . Western blotting of enriched proteins reveals a reduction in the total amount of Ub proteins in mutant samples (Fig. 2, E and F) . These results indicate that Hectd1 likely catalyzes the ubiquitination of multiple and/or highly abundant proteins.
Identification of Hsp90 as a candidate
Hectd1 substrate
HECT domain E3 Ub ligases physically interact with their substrates. To elucidate the pathways regulated by Hectd1, we conducted two independent proteomic screens to identify Hectd1 interactors and identified Hsp90 in both screens. We initially O was generated in an ENU mutagenesis screen and harbors a missense mutation resulting in truncation of Hectd1.
Hectd1
X is a gene trap allele where the Ub ligase domain is disrupted by insertion of a -geo (LacZ) cassette (Zohn et al., 2007) . HAHectd1 ANK consists of amino acids 1-551 of Hectd1 encompassing the ankyrin (ANK) domain. pCMVHA-Hectd1* is Ub ligase deficient because of mutation of the active site cysteine (C2579G Next we tested whether the interaction of Hectd1 with Hsp90 results in the ubiquitination of Hsp90. Hsp90 coexpressed with Hectd1 in HEK293T cells resulted in the appearance of HMW Ub-Hsp90 species (Fig. 4 A) . Furthermore, siRNAmediated knockdown of Hectd1 in HEK293T cells reduced the appearance of HMW Myc-Hsp90 (Fig. 4 B) . To discern the Ub n chain linkage specificity on Hsp90, HEK293T cells were transfected with Myc-Hsp90 along with wild-type Ub or Ub constructs where the critical lysine residues K48 or K63 were mutated to arginine (K48R-Ub and K63R-Ub, respectively). These mutant Ub proteins will incorporate into growing Ub chains, but if the mutated residue is utilized for chain elongation, the chain will fail to extend. In addition, a mutant Ub construct where all lysines in Ub are mutated to arginine (K0-Ub) was used as a negative control for chain elongation. Wild-type and K48R-Ub incorporated, whereas K0-Ub and K63R-Ub failed to incorporate into the Ub n chains on Hsp90 (Fig. 4 C) . This result indicates that Ub n on Hsp90 utilizes K63 linkages. Similarly, incorporation of K63-Ub n is increased in HEK293T cells transfected with HA-Hectd1 but not ligase-deficient HA-Hectd1* (Fig. 2 D) . Together, these observations indicate that the Hectd1-dependent appearance of HMW Hsp90 species is primarily caused by addition of K63 linkages. To determine the in vivo relevance of Hectd1-dependent Hsp90 ubiquitination, we tested whether mutation of Hectd1 in the embryo would have an effect on endogenous Ub n -Hsp90 levels. To ensure stabilization of Ub n -protein conjugates in the embryo, we devised a short-term embryo culture protocol in the presence of the well-characterized cell-permeable proteasome inhibitor MG132. To determine if Hectd1 influences Ub n of Hsp90 in vivo, E11.5 wild-type (Hectd1 W ) and mutant (Hectd1 X ) embryos were cultured in the presence of MG132, followed by immunoprecipitation of Hectd1 and Western blotting to detect Hsp90. The gene trap insertion in Hectd1 X disrupts the catalytic HECT domain but leaves the substrate interaction domains (Zohn et al., 2007 ) and the epitope recognized by our anti-Hectd1 of in vitro and in vivo binding assays. Myc-Hectd1 ANK and HA-Hsp90bd (the fragment identified in the yeast two-hybrid screen) bind in an in vitro binding assay (Fig. 3 D) and when coexpressed in HEK293T cells (Fig. 3 E) . Additionally, in HEK293T cells, full-length Myc-Hsp90 binds to both full-length wild-type ; WCL, whole cell lysate; IB, immunoblot; IP, immunoprecipitation; (Ub)n, Ub n ; wt-Ub, wild-type Ub; K48R, mutant Ub lysine 48 arginine; K63R, mutant Ub lysine 48 arginine; K0, lysineless Ub. Hectd1-dependent ubiquitination regulates Hsp90 • Sarkar and Zohn but rather influences other processes such as intracellular localization/trafficking (Mukhopadhyay and Riezman, 2007) . To determine if Hectd1-dependent K63-linked Ub n of Hsp90 regulates its intracellular localization, we examined the distribution of Hsp90 in primary CM cultures prepared from E10.5 Hectd1 W and Hectd1 X embryo heads. In Hectd1 W CM cultures, Hsp90 is localized in the cytoplasm as well as in the nucleus (Fig. 5 A) . In contrast, in Hectd1 X mutant cells, Hsp90 was concentrated at the plasma membrane in ruffled-like structures (Fig. 5 B, arrows) . To further investigate the plasma membrane localization of Hsp90, cells were immunostained with the primary anti-Hsp90 antibody before permeabilization with Triton X-100 to visualize only the Hsp90 localized to the outside of the plasma membrane. This experiment revealed extracellular localization of Hsp90 in Hectd1 O mutant but not Hectd1 W CM cells (Fig. 5, C and D) . In addition, we used an experimental paradigm to stimulate Hsp90 translocation to the membrane by treating HEK293T cells with proteasomal inhibitors (Verschuure et al., 2002) to examine the role of Hectd1 in controlling the intracellular localization of antibody intact (Fig. 2 A) . In Hectd1 W lysates, HMW Hsp90 that coimmunoprecipitated with Hectd1 is detected as multiple bands (Fig. 4 E) O primary CM cultures in a highly denaturing ubiquitination lysis buffer plus 5% SDS to minimize interaction of associated proteins demonstrates reduced ubiquitination of Hsp90 in Hectd1 mutant CM cells (Fig. 4 F) . Interestingly, coimmunoprecipitation of Hsp90 with a 30kD Ub n -protein is dependent on Hectd1 activity (Fig. 4 F,  asterisk) . The binding of Hsp90 to this protein in highly denaturing conditions indicates a tight association or possibly a proteolytically processed Hsp90 fragment.
Hectd1-dependent Ub n influences the cellular localization and secretion of Hsp90
The conjugation of K63-linked Ub n chains onto substrate proteins typically does not target them to the proteasome for degradation CM cells (Fig. 5 K) . Conversely, Hsp90 secretion was reduced in HEK293T cells cotransfected with Myc-Hsp90 along with HA-Hectd1 but not HA-Hectd1* (Fig. 5 L) . Together, these results demonstrate that Hectd1-dependent Ub n of Hsp90 targets it away from the membrane and the secretory pathway.
Enhanced migration of Hectd1 mutant CM cells is associated with increased
Hsp90 secretion
Secreted Hsp90 can enhance cell migration in numerous experimental paradigms (Tsutsumi and Neckers, 2007) . Therefore, our observations that Hectd1 regulates Hsp90 secretion and that in Hectd1 mutant CM cells Hsp90 secretion is increased suggest a potential molecular mechanism underlying the abnormal behavior of mutant CM cells (Fig. 1) . To establish that Hsp90 can stimulate emigration and migration of cells from CM explants, CM explants from wild-type embryos were microdissected, plated on fibronectin-coated plates, and incubated with recombinant Hsp90 protein. Treatment with Hsp90 significantly increased (P < 0.05) both the Hsp90. Myc-Hsp90 is localized to the cytoplasm in HEK293T cells cotransfected with either HA-Hectd1 or HA-Hectd1* (Fig. 5 Plasma membrane localization of Hsp90 has been associated with secretion of Hsp chaperones through the exosome pathway (Hegmans et al., 2004; Cheng et al., 2008; McCready et al., 2010 function of Hsp90 itself. Accordingly, our data demonstrate that Hectd1-dependent K63-Ub n of Hsp90 controls its intracellular localization and secretion.
Hectd1-dependent ubiquitination of Hsp90 regulates it secretion
Little is known about the pathways regulating secretion of Hsp90. Phosphorylation of Hsp90 by PKA on Thr90 promotes its secretion (Wang et al., 2009) . Furthermore, the four C-terminal amino acid residues of Hsp90 (EEVD) are critical for regulation of its secretion (Wang et al., 2009) . This domain provides a point of interaction for tetratricopeptide repeat (TPR) domain-containing proteins preventing secretion by docking Hsp90 in the cytoplasm (Wang et al., 2009) . Similarly, our data demonstrate that Hectd1 is a negative regulator of Hsp90 secretion. In contrast to the interaction of Hsp90 with TPR domain-containing proteins, our binding data demonstrate that Hectd1 interacts with Hsp90 through a region located between amino acids 241 and 617. It's important cells emigrating from the explants and the distance migrated (Fig. 6, A-D (Fig. 6, E-I) . Similarly, treatment of explants with dimethyl amiloride (DMA), an inhibitor of secretion, reduced emigration of CM cells from Hectd1 O mutant explants (Fig. 6, J-N) . Together, these data demonstrate that enhanced emigration and migration of Hectd1 mutant CM cell explants is at least partly caused by increased secretion of Hsp90 in the absence of Hectd1 ubiquitination activity.
Discussion
Here we demonstrate that Hectd1 is a functional Ub ligase and that Hectd1-dependent ubiquitination plays an essential role in controlling Hsp90 secretion by negatively regulating secretion of Hsp90. Our data indicate that Hectd1 binds to Hsp90 and is required for conjugation of K63-linked Ub n chains onto this cellular chaperone. Fig. 7 summarizes a model of how mutation of Hectd1 results in alterations in CM behavior that have emerged from this study. In the absence of Hectd1 Ub ligase activity, Hsp90 becomes concentrated at the cell surface of CM cells rather than its normal cytoplasmic distribution. Additionally, Hsp90 secretion is increased in Hectd1 mutant CM cells. This excessive secretion is at least partially responsible for the abnormal behavior of Hectd1 mutant CM cells. We propose that this abnormal CM behavior contributes to the failure of CM expansion found in Hectd1 mutant embryos. Because this CM defect is associated with failure of neural fold elevation ( Fig. 1 ; Zohn et al., 2007) , these results raise the distinct possibility that Hsp90 may be a critical Hectd1 substrate and that failure to regulate Hsp90 secretion in Hectd1 mutant CM may contribute to exencephaly in Hectd1 mutants.
Hectd1-dependent ubiquitination of Hsp90
Hsps have been shown to interact with other E3 Ub ligases, although a direct role in ubiquitination of these chaperones has not been demonstrated. The U-box E3 ligase, C terminus of Hsc70-interacting protein (CHIP) interacts with Hsp90, Hsp70, and Hsp40; however, instead of ubiquitinating these, CHIP acts as a quality controller by selectively targeting associated client proteins for degradation (McDonough and Patterson, 2003; Murata et al., 2003) . In contrast, our data demonstrate that Hectd1 is required for K63-Ub n of Hsp90 itself, raising the possibility that Hectd1-dependent ubiquitination of Hsp90 serves an alternate purpose beyond that of quality control of client proteins. Although our data do not rule out the distinct possibility that Hectd1 also regulates the selective ubiquitination of Hsp90 client proteins, in this study we restricted ourselves to examining the Ub conjugation and Figure 7 . Proposed model depicting consequences of Hectd1-mediated Hsp90 K63 ubiquitination from the present study. In wild-type CM cells, K63-ubiquitinated Hsp90 (red) is localized to the cytosol. Hsp90 secretion is properly regulated in CM of wild-type embryos, resulting in normal behavior of the CM and possibly normal expansion of the CM required for neural fold elevation. In Hectd1 mutant CM cells, the lack of K63 ubiquitination of Hsp90 results in an increased pool of Hsp90 targeted for secretion and localized to the membrane (red). Excess secretion of Hsp90 leads to abnormal behavior of the CM, potentially contributing to failure of CM expansion, neural fold elevation, and neural tube closure.
Materials and methods
Mice genotyping and cell culture Hectd1 opm and Hectd1 XC (Hectd1 X ) mouse lines have been described previously (Fig. 2 A; Kasarskis et al., 1998; Zohn et al., 2007 were genotyped using amplification refractory mutation system PCR (ARMS-PCR; Ye et al., 2001 ) and gap PCR (Bandyopadhyay et al., 2004) , respectively, and as shown (Fig. S3) . For ARMS-PCR to genotype Hectd1 opm , the primers used were: forward inner primer (A allele), 5-AGGGGCAGTCTTTGAGGCTGGTGGATA-3; reverse inner primer (T allele), 5-TGTCACGAATGAAGGTNAGAACACAATACA-3; forward outer primer, 5-ACCTTGTGTCTCTGTTGTAGGTGCTGGA-3; and reverse outer primer, 5-GCTCCATTTTGCCACAGAGTCTCGATAC-3. Mice carrying the Hectd1 X gene trap allele were genotyped using gap PCR. The primers used were 52860334F, 5-CACTGAAAGTGACGGGGCTTG-GAAC-3; 52859614R, 5-ATAATAATAAAGCACTTAACTATTCCCGAG-3; and B-Gal-Rev1, 5-GACAGTATCGGCCTCAGGAAGATCG-3. CM cultures were prepared according to a standard protocol for isolating mouse embryonic fibroblasts (MEFs) from E12.5 mouse embryo heads (Nagy et al., 2003) . HEK293T and CM cells were cultured in DME (Invitrogen) , supplemented with 10% FCS, 100 IU/ml penicillin G, and 100 µg/ml streptomycin sulfate (Invitrogen) . Bright field images for whole embryos were obtained using a microscope (Discover V8; Carl Zeiss) using an Achromat S FWD 107 mm lens with a magnification of 0.63×. Images were captured using a camera (AxioCam ERc 5s; Carl Zeiss) and processed with Photoshop (8.0) and Illustrator (10.0; both from Adobe).
Mammalian expression constructs pGBKT7-Hectd1 ANK , pCMV-HA-Hectd1 ANK , pCMV-HA-Hectd1, and pCMV-HA-Hectd1* were assembled by ligation of RT-PCR generated fragments and ESTs encoding fragments of mouse Hectd1 (Fig. 2) . pCMV-Sport6-Hsp90aa1 expression plasmid was obtained from Invitrogen (Clone ID no. 6491307) and subcloned into pCMV-Myc (Takara Bio Inc.). EGFP-C1-UbKO was obtained from Addgene (Addgene plasmid 11934; Bergink et al., 2006) . pCMV-FLAG-Ub, pCMV-FLAG-K63R-Ub, and pCMV-FLAG-K48R-Ub were provided by Drs. H. McLauchlan and P. Cohen (University of Dundee, Dundee, Scotland, UK; Windheim et al., 2008) . Control, scrambled, and custom Hectd1 (5-AGATAAAGGTGGTGATATA-3) siRNA were purchased from Thermo Fisher Scientific. The effectiveness of the Hectd1 siRNA was demonstrated by transfection of HEK293T cells with control, scrambled, and Hectd1 constructs followed by Western blotting to detect Hectd1 (Fig. S4) 
Proteomic screens
The Matchmaker Two-Hybrid System 3 was used according to manufacturer's instructions to screen the Matchmaker Pretransformed E11.5 mouse cDNA library (Takara Bio Inc.) for proteins that bind to Hectd1 ANK . For the LC-MS screen, Hectd1 was immunoprecipitated in immunoprecipitation buffer (50 mM Tris, pH 7.5, 1 mM EDTA, 150 mM NaCl, and 0.1% Triton X-100 with protease inhibitor cocktail) from lysates of wild-type E10.5 mouse; embryo heads were resolved on 3-8% Tris-acetate denaturing gels (Invitrogen) and processed (Jensen et al., 1999; Cargile et al., 2004; Essader et al., 2005) . Peptide sequences were searched against the mouse Uniprot protein database (http://www.uniprot.org/) using the Sequest algorithm in the Bioworks Browser software package (Thermo Fisher Scientific).
Antibodies and immunofluorescence assay Anti-peptide Hectd1 rabbit polyclonal antibody was generated (Biosynthesis Inc.) against mouse Hectd1 amino acids 487-505 (CPVNKGDD-KKKDTNKDEE) and used for all experiments unless otherwise indicated. The specificity of the Hectd1 antibody was confirmed in an immunoblotting assay (Fig. S1 ). Serum from rabbits immunized with Hectd1 peptide was used for Western blot analysis or affinity purified using the RAP Affinity Purification kit (Invitrogen) for immunoprecipitation. For enrichment of Ub proteins that bind to Rad23, the ubiquitinated protein enrichment kit (EMD) was used according to the manufacturer's instructions. Other antibodies used were: HSP90 (E289) antibody (4875; Cell Signaling Technology), anti-Hsp90 mouse monoclonal antibody (mAb; EMD-17D7, CA1023; EMD), HSP90 (ADI-SPS-771; Enzo Life Sciences), mAb to mono-and polyubiquitinylated protein conjugates FK2H (BML-PW0150; Enzo Life Sciences), FK1 mAb to polyubiquitinylated to note that it is not simply the interaction of Hectd1 with Hsp90 that prevents its secretion; the Ub ligase activity of Hectd1 is also required. K63-linked Ub regulates trafficking of proteins in numerous systems (Mukhopadhyay and Riezman, 2007) . It remains to be determined how Hectd1-dependent ubiquitination of Hsp90 prevents its secretion. One clue comes from our finding that a Hectd1-dependent 30-kD Ub protein coimmunoprecipitates with Hsp90 under highly denaturing conditions. This could either represent a tightly associated protein or a cleavage product of Hsp90. It is possible that association of Hsp90 with this 30-kD Ub protein prevents membrane translocation. Alternatively, Hectd1-dependent K63-Ub n of Hsp90 may lead to cleavage of Hsp90 to a fragment that cannot be secreted. Precisely how Hectd1-dependent ubiquitination regulates Hsp90 secretion remains to be determined.
Hectd1-dependent ubiquitination of Hsp90 regulates CM cell behavior
Our data support the model that abnormal behavior of CM cells is mediated by increased secretion of Hsp90 in mutant cells (Fig. 7) . Increased extracellular Hsp90 is sufficient to induce increased emigration from CM explants. Additionally, emigration and migration of cells from Hectd1 mutant CM explants is highly dependent on secretion of Hsp90. How might abnormal behavior of the CM result in failure of neural fold elevation? Current models of cranial neural tube closure predict that a driving force for cranial neural fold elevation is the expansion of the extracellular matrix, displacing CM cells and resulting in expansion of the space between cells (Morriss and Solursh, 1978a,b; Schoenwolf and Fisher, 1983; Morris-Wiman and Brinkley, 1990a,b,c; Copp, 2005) . Our data demonstrate that the abnormal behavior of Hectd1 mutant CM is related to the excess secretion of Hsp90. We propose that the abnormal behavior of the CM in Hectd1 mutants interferes with the expansion of the CM that occurs as the extracellular matrix expands, resulting in the dense CM found in Hectd1 mutants. The substrates of extracellular Hsp90 include cell surface receptors and extracellular matrix components and likely a host of other client proteins, which can regulate cell behavior (Tsutsumi and Neckers, 2007; Li et al., 2012; Sims et al., 2011) . Thus, excess extracellular Hsp90 in the CM may influence expansion of the extracellular matrix, interaction of CM cells with the extracellular matrix, and/or motility of the CM cells. Our previous observation that the increased density of CM in Hectd1 mutants was not associated with alterations in cell proliferation and apoptosis (Zohn et al., 2007) supports the hypothesis that increased CM density is caused by effects on cell rearrangements. Whether this abnormal cellular behavior is truly responsible for the failed CM expansion and neural tube closure in Hectd1 mutants still remains to be determined. It is important to note that Hectd1 likely has multiple substrates, as demonstrated from our proteomic screens, and it is possible that these also contribute to the abnormal CM behavior and NTDs in Hectd1 mutants. In conclusion, our study establishes a novel Ub ligase-substrate interaction in vivo between Hectd1 and Hsp90 and provides a molecular mechanism for the abnormal migratory behavior of the CM in Hectd1 mutants. Hectd1-dependent ubiquitination regulates Hsp90 • Sarkar and Zohn lenses of NA 0.4 and 0.85, respectively. Images were taken using a DP71 camera (Olympus). Digital images were acquired using DPController and DPManager software (Olympus) and processed with Photoshop (8.0) and Illustrator (10.0). Cells were imaged using bright field microscopy at 100× magnification. Cell perimeters (n = 130) were computed using NeuronJ (http://www.imagescience.org/meijering/software/neuronj/), and cell areas (n = 130) were computed using ImageJ (http://rsbweb.nih .gov/ij/). Cell shape was defined using the equation (4 × cell area/cell perimeter 2 ), where >1 indicates a perfect circle and values <1 indicate a more irregular shape.
Cell migration assays and quantification For explant migration assays, E8.5 Hectd1 WT and Hectd1 O embryos were collected and washed in 1× PBS, and explants were microdissected from the CM, taking care to remove the neural epithelium and surface ectoderm. Explants were cultured for 24 h on fibronectin-coated glass coverslips in DME containing 10% FBS with or without 25 µg/ml anti-Hsp90 antibody as described previously (Sidera et al., 2008) . Explants were photographed using a microscope (CKX41; Olympus) with the 40×/NA 0.55 objective lens. Images were captured using a DP70 camera (Olympus) and processed with Photoshop (8.0) and Illustrator (10.0). The mean migratory distance from the circumference of the explant to the migratory front and the mean cell number in unit area (200 µm 2 ) perpendicular and mid-distant between the migratory front and explant circumference (dotted lines) were quantitated. Results are expressed as the mean migratory distance (in micrometers) of 50 randomly chosen cells at the migrating front and the mean number of migrating cells in 10 randomly chosen squares of unit area (200 µm 2 ) at a mid-distance between the explant circumference and the migrating front, perpendicular to the explant circumference. Inhibition of secretory mechanisms was achieved by treatment of explants for 16 h in 200 µM DMA, whereas control explants were treated with DMSO vehicle. Statistical significance of differences of means was tested with a paired two-tailed Student's t test.
Online supplemental material Fig. S1 shows the specificity of the anti-Hectd1 antibody used in this study. Fig. S2 shows colocalization of Hectd1 and Hsp90 in HEK293T cells. Fig. S3 shows the genotyping strategy to identify Hectd1 opm and Hectd1 X . Fig. S4 shows the effectiveness of the siRNA targeting Hectd1 in reducing protein expression when transfected in HEK293T cells. Online supplemental material is available at http://www.jcb.org/cgi/content/ full/jcb.201105101/DC1. goat anti-mouse IgG (H+L; A11029; Invitrogen), and Alexa Fluor 546 donkey anti-goat IgG (H+L; A11056; Invitrogen). Because of the high homology between Hsp90 family members, we confirmed antibody specificity against Hsp90 and - in transfected HEK293T lysates. Our results demonstrate that the Hsp90 antibody (no. 4877; Cell Signaling Technology) recognizes both  and  subtypes, whereas the Hsp90 (no. SPS-771; Enzo Life Sciences) uniquely recognizes Hsp90. We did not identify an antibody that uniquely recognizes Hsp90. To detect extracellular Hsp90, live cells were treated with anti-Hsp90 antibody without permeabilization with Triton X-100 for 3 h at 37°C before fixation. In contrast, all other immunofluorescence experiments were performed as described previously (Zohn et al., 2006) . In brief, cells were fixed for 20 min in 4% paraformaldehyde, washed in PBS, and permeabilized in PBS + 0.1% Triton X-100. Primary antibody incubations were performed overnight and secondary antibody incubations were performed for 20 min. Immunofluorescence images were obtained at 25°C with a fluoromount mounting medium (Sigma-Aldrich) using a confocal microscope (LSM-510; Carl Zeiss) with the 63× objective lens (Plan-Apochromat NA 1.4 oil, differential interference contrast). Digital images were acquired using AxioVision LE software (Carl Zeiss) and processed with Photoshop (8.0) and Illustrator (10.0).
Co-immunoprecipitation, ubiquitination assays, and ELISA For in vitro binding assays, biotinylated peptides were synthesized using the TNT T7 Coupled Reticulocyte Lysate system and Transcend tRNA (Promega). Binding assays were performed on precleared lysates at 25°C for 1 h using the Matchmaker Co-IP kit (Takara Bio Inc.) and Western blots developed using the Transcend Chemiluminescent Non-Radioactive Translation Detection system (Promega). Binding assays in HEK293T cells were performed at 4°C for 18 h as described previously (Zohn et al., 2006) . For lenient binding conditions, a mild immunoprecipitation buffer (50 mM Tris, pH 7.5, 1 mM EDTA, 150 mM NaCl, and 0.1% Triton X-100 with protease inhibitor cocktail) was used, and for stringent binding conditions, radioimmunoprecipitation assay buffer (no. 89901; Thermo Fisher Scientific) with protease inhibition cocktail (Roche) was used. For ubiquitination assays in HEK293T cells, 44 h after transfection, cells were treated with the proteasome inhibitor MG132 (20 µM; Sigma-Aldrich) for 4 h, washed in ice-cold PBS, and lysed in ubiquitination lysis buffer (50 mM Tris, pH 7.5, 1 mM EDTA, 150 mM NaCl, 0.1% Triton X-100, complete protease inhibitor cocktail, 100 µM MG132, 20 µM Ub aldehyde, and 100 µM N-ethylmalemide). Images of Western blot gels were acquired with a ChemiDoc XRS system (Bio-Rad Laboratories) and Quality One (4.6.3) software or using the Odyssey infrared imaging system (LI-COR Biosciences) and processed with Photoshop (8.0) and Illustrator (10.0). Scanned films were quantified using ImageJ software (http://rsb .info.nih.gov/ij/). To quantify ubiquitination assays, the whole lane from the well to the bottom of the gel was used for quantification. Statistically significant differences were assessed by a paired two-tailed Student's t test. All statistical analyses were performed using MS Excel software (Microsoft). Differences were considered to be significant for values of P < 0.05.
Cell shape assay 10 embryos each of wild type and Hectd1 mutant at E9.5 were fixed and stained using the hematoxylin and eosin method as described previously (Zohn et al., 2007) . Bright field images were acquired using a microscope (BX61; Olympus) at 10× and 40× magnification, with objective
